Skip to main content

Table 5 Associations of SRC-3 haplotypes

From: Nuclear receptor coregulator SNP discovery and impact on breast cancer risk

Haplotypesa

Cases (%)

Controls (%)

OR

95% CI

P

CGA

1847 (77.0)

2199 (75.0)

1

  

CCA

227 (9.5)

298 (10.1)

0.91

0.75-1.09

0.2963

CGG

205 (8.5)

267 (9.1)

0.91

0.75-1.11

0.3597

TGA

119 (4.9)

162 (5.5)

0.87

0.68-1.12

0.2824

CCG

0 (0.0)

8 (0.3)

0.07

0.004-1.21

0.0096

TCG

2 (0.1)

1 (0.0)

2.38

0.22-26.28

0.4651

TGG

0 (0.0)

1 (0.0)

0.39

0.02-9.74

0.3659

  1. a haplotypes representing the alleles of C218R, Q586H and T960T compared with wildtype. Haplotype frequencies of SRC-3 polymorphisms C218R, Q586H and T960T in the German study population compared with the, odds ratios (OR) with 95% confidence intervals (95% CI) and P-values.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us